de State Street Ionis Pharmaceuticals IONS Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 344 M | Comprar |
4,334,848
+339,284
| +8% | +USD 25.5 M | 0.01% | 747 |
|
|
2026
Q1 | USD 300 M | Comprar |
3,995,564
+20,699
| +0.5% | +USD 1.63 M | 0.01% | 754 |
|
|
2025
Q4 | USD 314 M | Vender |
3,974,865
-413,786
| -9% | -USD 31.2 M | 0.01% | 734 |
|
|
2025
Q3 | USD 287 M | Vender |
4,388,651
-141,747
| -3% | -USD 6.92 M | 0.01% | 763 |
|
|
2025
Q2 | USD 179 M | Vender |
4,530,398
-314,735
| -6% | -USD 10.3 M | 0.01% | 979 |
|
|
2025
Q1 | USD 146 M | Vender |
4,845,133
-581,280
| -11% | -USD 19 M | 0.01% | 1070 |
|
|
2024
Q4 | USD 190 M | Comprar |
5,426,413
+576,276
| +12% | +USD 21.5 M | 0.01% | 970 |
|
|
2024
Q3 | USD 194 M | Comprar |
4,850,137
+659,632
| +16% | +USD 30.7 M | 0.01% | 935 |
|
|
2024
Q2 | USD 200 M | Comprar |
4,190,505
+34,841
| +0.8% | +USD 1.43 M | 0.01% | 859 |
|
|
2024
Q1 | USD 180 M | Comprar |
4,155,664
+146,867
| +4% | +USD 7 M | 0.01% | 925 |
|
|
2023
Q4 | USD 203 M | Comprar |
4,008,797
+53,768
| +1% | +USD 2.58 M | 0.01% | 834 |
|
|
2023
Q3 | USD 179 M | Vender |
3,955,029
-19,424
| -0.5% | -USD 801 k | 0.01% | 830 |
|
|
2023
Q2 | USD 163 M | Vender |
3,974,453
-93,881
| -2% | -USD 3.61 M | 0.01% | 905 |
|
|
2023
Q1 | USD 145 M | Vender |
4,068,334
-150,395
| -4% | -USD 5.65 M | 0.01% | 951 |
|
|
2022
Q4 | USD 159 M | Comprar |
4,218,729
+457,774
| +12% | +USD 19.3 M | 0.01% | 865 |
|
|
2022
Q3 | USD 166 M | Vender |
3,760,955
-441,919
| -11% | -USD 18.6 M | 0.01% | 804 |
|
|
2022
Q2 | USD 156 M | Comprar |
4,202,874
+172,228
| +4% | +USD 6.49 M | 0.01% | 875 |
|
|
2022
Q1 | USD 149 M | Comprar |
4,030,646
+124,271
| +3% | +USD 4.07 M | 0.01% | 1021 |
|
|
2021
Q4 | USD 119 M | Comprar |
3,906,375
+385,061
| +11% | +USD 12.1 M | 0.01% | 1159 |
|
|
2021
Q3 | USD 118 M | Comprar |
3,521,314
+290,363
| +9% | +USD 10.9 M | 0.01% | 1140 |
|
|
2021
Q2 | USD 129 M | Vender |
3,230,951
-178,620
| -5% | -USD 7 M | 0.01% | 1110 |
|
|
2021
Q1 | USD 153 M | Vender |
3,409,571
-503,757
| -13% | -USD 28.1 M | 0.01% | 925 |
|
|
2020
Q4 | USD 221 M | Comprar |
3,913,328
+358,434
| +10% | +USD 17.9 M | 0.01% | 712 |
|
|
2020
Q3 | USD 169 M | Vender |
3,554,894
-35,529
| -1% | -USD 1.97 M | 0.01% | 742 |
|
|
2020
Q2 | USD 212 M | Vender |
3,590,423
-302,471
| -8% | -USD 16.8 M | 0.02% | 646 |
|
|
2020
Q1 | USD 184 M | Comprar |
3,892,894
+45,509
| +1% | +USD 2.54 M | 0.02% | 631 |
|
|
2019
Q4 | USD 232 M | Comprar |
3,847,385
+196,602
| +5% | +USD 11.7 M | 0.02% | 663 |
|
|
2019
Q3 | USD 219 M | Comprar |
3,650,783
+65,104
| +2% | +USD 4.24 M | 0.02% | 656 |
|
|
2019
Q2 | USD 230 M | Comprar |
3,585,679
+1,032,591
| +40% | +USD 73 M | 0.02% | 650 |
|
|
2019
Q1 | USD 207 M | Comprar |
2,553,088
+17,919
| +0.7% | +USD 1.16 M | 0.02% | 669 |
|
|
2018
Q4 | USD 137 M | Vender |
2,535,169
-479,547
| -16% | -USD 24.5 M | 0.01% | 751 |
|
|
2018
Q3 | USD 156 M | Vender |
3,014,716
-44,302
| -1% | -USD 2.08 M | 0.01% | 816 |
|
|
2018
Q2 | USD 127 M | Comprar |
3,059,018
+93,771
| +3% | +USD 4.16 M | 0.01% | 883 |
|
|
2018
Q1 | USD 131 M | Comprar |
2,965,247
+212,705
| +8% | +USD 10.8 M | 0.01% | 850 |
|
|
2017
Q4 | USD 138 M | Vender |
2,752,542
-189,279
| -6% | -USD 10.4 M | 0.01% | 838 |
|
|
2017
Q3 | USD 149 M | Vender |
2,941,821
-22,169
| -0.7% | -USD 1.16 M | 0.01% | 777 |
|
|
2017
Q2 | USD 151 M | Vender |
2,963,990
-376,481
| -11% | -USD 17.5 M | 0.01% | 760 |
|
|
2017
Q1 | USD 134 M | Comprar |
3,340,471
+567,792
| +20% | +USD 25.5 M | 0.01% | 805 |
|
|
2016
Q4 | USD 133 M | Vender |
2,772,679
-811,925
| -23% | -USD 32.1 M | 0.01% | 775 |
|
|
2016
Q3 | USD 131 M | Vender |
3,584,604
-662,307
| -16% | -USD 20.7 M | 0.01% | 750 |
|
|
2016
Q2 | USD 98.9 M | Comprar |
4,246,911
+1,209,523
| +40% | +USD 39 M | 0.01% | 840 |
|
|
2016
Q1 | USD 123 M | Comprar |
3,037,388
+412,515
| +16% | +USD 16.8 M | 0.01% | 764 |
|
|
2015
Q4 | USD 163 M | Comprar |
2,624,873
+126,047
| +5% | +USD 6.8 M | 0.02% | 668 |
|
|
2015
Q3 | USD 101 M | Vender |
2,498,826
-2,005
| -0.1% | -USD 104 k | 0.01% | 823 |
|
|
2015
Q2 | USD 144 M | Vender |
2,500,831
-670,000
| -21% | -USD 42.6 M | 0.02% | 721 |
|
|
2015
Q1 | USD 202 M | Comprar |
3,170,831
+590,384
| +23% | +USD 40.1 M | 0.02% | 599 |
|
|
2014
Q4 | USD 159 M | Vender |
2,580,447
-96,105
| -4% | -USD 4.74 M | 0.02% | 673 |
|
|
2014
Q3 | USD 104 M | Comprar |
2,676,552
+268,934
| +11% | +USD 9.5 M | 0.01% | 811 |
|
|
2014
Q2 | USD 82.9 M | Vender |
2,407,618
-215
| -0% | -USD 6.77 k | 0.01% | 949 |
|
|
2014
Q1 | USD 104 M | Comprar |
2,407,833
+13,556
| +0.6% | +USD 657 k | 0.01% | 842 |
|
|
2013
Q4 | USD 95.4 M | Vender |
2,394,277
-251,984
| -10% | -USD 8.98 M | 0.01% | 860 |
|
|
2013
Q3 | USD 99.3 M | Vender |
2,646,261
-64,158
| -2% | -USD 1.92 M | 0.01% | 822 |
|
|
2013
Q2 | USD 72.8 M | Comprar |
+2,710,419
| Nuevas | +USD 57.6 M | 0.01% | 903 |
|
Otros fondos que tienen IONS en su cartera
Posición de State Street en IONS: resumen de T2 2026
State Street aumentó su participación en Ionis Pharmaceuticals (IONS) en 8.5% durante T2 2026, al comprar aproximadamente USD 25.5 M y elevar la posición a 4,334,848 acciones con un valor de USD 344 M. La posición representa 0.01% de la cartera y ocupa el puesto #747.
State Street reportó por primera vez una posición en IONS en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank mantienen una posición en IONS.
- Al cierre de T2 2026, State Street tenía 4,334,848 acciones de Ionis Pharmaceuticals con un valor de USD 344 M.
- State Street compró 339,284 acciones de Ionis Pharmaceuticals en T2 2026, por un monto estimado de USD 25.5 M.
- Ionis Pharmaceuticals representó 0.01% de la cartera de State Street en T2 2026 y fue su posición número 747.
- State Street reportó por primera vez una posición en Ionis Pharmaceuticals en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 516 fondos que sigue Wall St. Rank tenían Ionis Pharmaceuticals en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.